| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
8 |
| Employees |
23 |
| Revenues (TTM) (Millions $) |
2 |
| Net Income (TTM) (Millions $) |
-35 |
| Cash Flow (TTM) (Millions $) |
-22 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Lumos Pharma Inc is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics for rare diseases. The company primarily targets disorders with serious unmet medical needs and limited treatment options. They aim to bring innovative and effective treatments to patients suffering from these rare diseases. Lumos Pharma's pipeline includes candidates for diseases like Creatine Transporter Deficiency, Pediatric Growth Hormone Deficiency, and Mucopolysaccharidosis Type III. Their mission is to improve patients' quality of life and become a leading player in the rare disease therapeutics market.
Company Address: 4200 Marathon Blvd #200 Austin 78756 TX
Company Phone Number: 215-2630 Stock Exchange / Ticker: NASDAQ LUMO
|
%
